Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ibuka

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Clinical Nuclear Medicine|April 1, 1990
Clinical study of urinary excretion of Ga-67S Nakano, Y Hasegawa, K Ibuka, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|November 1, 1983
[Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma]Y Hasegawa, S Nakano, A Noguchi, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1992
[Evaluation of 99mTc-PMT delayed imaging in diagnosis of hepatocellular carcinoma]Y Hasegawa, S Nakano, K Ibuka, et al.
European Journal of Nuclear Medicine|January 1, 1985
Concentration of 99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomasY Hasegawa, S Nakano, K Ibuka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1984
The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agentY Hasegawa, S Nakano, K Ibuka, et al.
Cancer|January 15, 1986
Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imagingY Hasegawa, S Nakano, K Ibuka, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Nuclear Medicine|April 1, 1990
Clinical study of urinary excretion of Ga-67S Nakano, Y Hasegawa, K Ibuka, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|November 1, 1983
[Clinical evaluation of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan (99mTc-PMT) in diagnosis of hepatoma]Y Hasegawa, S Nakano, A Noguchi, et al.
Kaku Igaku. the Japanese Journal of Nuclear Medicine|March 1, 1992
[Evaluation of 99mTc-PMT delayed imaging in diagnosis of hepatocellular carcinoma]Y Hasegawa, S Nakano, K Ibuka, et al.
European Journal of Nuclear Medicine|January 1, 1985
Concentration of 99mTc-Sn-N-pyridoxyl-5-methyltryptophan, a biliary agent, in distant metastases of hepatomasY Hasegawa, S Nakano, K Ibuka, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1984
The importance of delayed imaging in the study of hepatoma with a new hepatobiliary agentY Hasegawa, S Nakano, K Ibuka, et al.
Cancer|January 15, 1986
Specific diagnosis of hepatocellular carcinoma by delayed hepatobiliary imagingY Hasegawa, S Nakano, K Ibuka, et al.
Pageof 2